Stryker's free cash flow over the last twelve months reached approximately 137% of its reported net income, signaling a cash-generation strength that the market may be overlooking amid a recent cyberattack and a 17.6% stock decline over the past year. The company reiterated full-year organic net sales growth guidance of 8% to 9.5%, despite first-quarter organic sales growth of just 2.4%, and its robust cash conversion provides the financial fuel to absorb incident costs and fund operational recovery without sacrificing long-term investments. This cash-flow fortress supports the credibility of management's rebound target and suggests the underlying business is healthier than the recent disruption implies.
Stryker CorporationStrong free cash flow at 137% of net income signals financial resilience and supports management's rebound target, despite recent cyberattack and stock decline.